Type of investment: Large-cap growth stock
The pharmacy benefit manager is profiting from the aging of boomers, health reform, patent expirations on name-brand drugs, and its recent acquisition of Medco, according to Puglia.
Get quote:
ESRXNEXT: FedEx
By Carla Fried, Anne C. Lee, Elaine Pofeldt, Susie Poppick and Penelope Wang
@Money
- Last updated June 26 2012: 5:07 PM ET